Form D/A — Innovatus Life Sciences Offshore Fund I-A, LP
0001811630-25-000002 · filed Mar 21, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Reported offering amount
- —
- Reported amount sold
- $10,000,000
- Minimum investment
- $2,000,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Innovatus Life Sciences Offshore Fund I-A, LP
- CIK
- 1811630
- Entity
- Limited Partnership
- Jurisdiction
- CAYMAN ISLANDS
- Year incorporated
- —
- Address
- 777 THIRD AVENUE, 25TH FLOOR
NEW YORK, New York 10017 - Phone
- 212.698.4595
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A Innovatus Capital Partners, LLC · PromoterNew York, New York Find on LinkedIn ↗
-
N/A Innovatus Life Sciences Offshore GP, LP · Executive OfficerGrand Cayman, Cayman Islands Find on LinkedIn ↗
-
David Schiff · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Andrew Dym · Executive OfficerNew York, New York Find on LinkedIn ↗
-
Andrew Hobson · Executive OfficerNew York, New York Find on LinkedIn ↗
-
N/A Innovatus Flagship Offshore Parent GP, LLC · Executive OfficerGrand Cayman, Cayman Islands Find on LinkedIn ↗
-
Sean Wilke · Executive OfficerNew York, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗